Table 4 Comparison between group 1 and group 2 patients as regards clinical features at the time of the study, laboratory parameters at the time of the disease diagnosis and colchicine dosage

Fever^a

40 (97.6%)

144 (90.6%)

0.201

Chest pain^a

23 (56.1%)

47 (29.6%)

0.001

Abdominal pain^a

40 (97.6%)

154 (96.9%)

1

Erythematous-like erythema^a

9 (22.0%)

7 (4.4%)

0.001

Testicular affection^b

6 (26%)

4 (5.5%)

0.006

HSP^a

3 (7.3%)

12 (7.5%)

1

Hb(mg/dl)^c

11.30 ± 1.31

11.67 ± 1.29

0.098

TLC(*1000)^c

8.66 ± 3.54

8.56 ± 3.57

0.643

PLT(*1000)^c

360.20 ± 92.51

344.81 ± 120.20

0.206

ESR^c

45.10 ± 29.35

35.36 ± 27.17

0.028

CRP^c

26.72 ± 17.50

27.51 ± 27.77

0.591

Persistant proteinuria (frequency %)^b

0 (0.0%)

1 (0.6%)

1

Colchicine dosage at time of study (g)^c

1.46 ± 0.53

1.13 ± 0.45

< 0.001